GE Potential This was posted on the MKI board and illustrates the importance of a company like GE being on board. I like MKI as well, looks like great technology.
A good comparison would be Clarient (OTC: CLRT) which was an otcbb medical diagnostics company that researched non-invasive oncological monitoring and imaging. Similar to Medipattern, Clarient was collaborating with GE Healthcare in the development of Clarient's imaging products. Clarient was a penny stock, and was primarily focused on the research and development of cancer imaging products.
On October 22, 2010. GE Healthcare announced that it would end it's collaboration with Clarient, by purchasing the company in an all cash deal for $580M or $5.00/share.
Similar valuations, considering outstanding common and preferred shares, would value this company near $7.40, if a $580M buyout were to be considered. Now, seeing where we are now, this is optimistic I agree.
However, at these levels ... the market has yet to price in the significance of the Visualize: Vascular product. Clearly, GE Healthcare and Navix Diagnostics have put priority on Medipattern's diagnostic imaging products, something that the market will, in time, come to appreciate. For the market to become more speculative in this stock, they will want to see revenue or earnings growth.